Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Other Accumulated Expenses (2022 - 2023)

Historic Other Accumulated Expenses for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to $221000.0.

  • Therapeutics' Other Accumulated Expenses fell 5376.57% to $221000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $221000.0, marking a year-over-year decrease of 5376.57%. This contributed to the annual value of $1.4 million for FY2022, which is N/A changed from last year.
  • As of Q3 2023, Therapeutics' Other Accumulated Expenses stood at $221000.0, which was down 5376.57% from $3.1 million recorded in Q2 2023.
  • Therapeutics' Other Accumulated Expenses' 5-year high stood at $4.9 million during Q1 2023, with a 5-year trough of $179000.0 in Q2 2022.